HFA Premium Access

The value of NT-proBNP in the diagnosis of cardiac disease in patients with alcoholic liver cirrhosis

Congress Session

About the speaker

Associate Professor Pavel Lazarev

RUDN University, Moscow (Russian Federation)
1 presentation
0 follower

24 more presentations in this session

Not changes in heart failure therapy but patient characteristics at admission predict unsuccessful guidance of therapy to a target of more than 30% NT-proBNP reduction

Speaker: Miss S. Stienen (Amsterdam, NL)

Thumbnail

Sacubitril/valsartan prevents the acute increase of n-terminal brain natriuretic peptide induced by exercise training in subjects with heart failure

Thumbnail

The diagnostic and economic implications of using a plasma nt-probnp of 300 or 400ng/litre as the threshold for ruling out the diagnosis of heart failure in a non selected british population

Speaker: Doctor J. Webb (London, GB)

Thumbnail

Natriuretic peptides for detection of heart failure in patients with atrial fibrillation from the community

Speaker: Professor F. Rutten (Utrecht, NL)

Thumbnail

Diagnostic accuracy of plasma ntprobnp in patients over 80 years of age in a non selected british population

Speaker: Miss J. Draper (London, GB)

Thumbnail

Access the full session

Poster Session 2 - Biomarkers

Speakers: Associate Professor P. Lazarev, Miss S. Stienen, Doctor J. Webb, Professor F. Rutten, Miss J. Draper
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk